• Users Online: 264
  • Print this page
  • Email this page
This article has been cited by
1Efficacy and Safety of an Aflibercept Treat-and-Extend Regimen in Treatment-Naïve Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion (CRVO): A Prospective 12-Month, Single-Arm, Multicentre Trial
Jose Garcia-Arumi,Francisco Gómez-Ulla,Navea Amparo,Enrique Cervera,Alex Fonollosa,Luis Arias,Javier Araiz,Juan Donate,Marta Suárez de Figueroa,Lucia Manzanas,Jaume Crespí,Roberto Gallego
Journal of Ophthalmology.2018;2018()1
[DOI]
2Central retinal vein occlusion secondary to severe iron-deficiency anaemia resulting from a plant-based diet and menorrhagia: a case presentation
Verlyn Yang,Liam Daniel Turner,Fraser Imrie
BMC Ophthalmology.2020;20(1)1
[DOI]
3Effects of ripasudil, a ROCK inhibitor, on retinal edema and nonperfusion area in a retinal vein occlusion murine model
Yoshifumi Hida,Shinsuke Nakamura,Anri Nishinaka,Yuki Inoue,Masamitsu Shimazawa,Hideaki Hara
Journal of Pharmacological Sciences.2018;137(2)129
[DOI]
4Extended release of dexamethasone from oleogel based rods
Russell Macoon,Timothy Guerriero,Anuj Chauhan
Journal of Colloid and Interface Science.2019;555(2)331
[DOI]
5Comparative efficacy of bevacizumab, ranibizumab, and aflibercept for treatment of macular edema secondary to retinal vein occlusion: a systematic review and network meta-analysis
Sermsiri Sangroongruangsri,Tanapat Ratanapakorn,Olivia Wu,Thunyarat Anothaisintawee,Usa Chaikledkaew
Expert Review of Clinical Pharmacology.2018;11(9)903
[DOI]